CADL icon

Candel Therapeutics
CADL

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$24
269% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Citigroup
Citigroup
Yigal Nochomovitz
50% 1-yr CADL win rate
13 Mar ‘26 1 month ago
Canaccord Genuity
Canaccord Genuity
John Newman
0% 1-yr CADL win rate
13 Mar ‘26 1 month ago